CVS Health has reported its second-quarter earnings, with total revenues increasing by 8.4% to $98.9 billion compared to the prior year. The company’s GAAP diluted EPS was $0.80, while Adjusted EPS reached $1.81.
The company also generated $6.5 billion in cash flow from operations year-to-date. In operational highlights, Aetna delivers advances in care navigation, CVS Pharmacy agreed to acquire certain prescription files and store locations from Rite Aid, and CVS Caremark demonstrated market-leading innovation in strong renewal and sales season.
For 2025, the company raised its guidance for GAAP diluted EPS to $3.84-$3.94, Adjusted EPS to $6.30-$6.40, and cash flow from operations to at least $7.5 billion.
CEO David Joyner attributed the company’s strong performance to its focus on operational and financial improvement across businesses, highlighting the significant recovery at Aetna, retention at CVS Caremark, and growth at CVS Pharmacy.
Source: https://www.cvshealth.com/news/company-news/cvs-health-corporation-reports-second-quarter-2025-results-and-updates-full-year-2025.html